Montana’s plan to become an experimental medical hub just pushed forward

Montana has established a pathway for biotech companies to sell experimental drugs to consumers after preliminary testing, requiring a $12,500 application fee and approval by a review board. The law allows access to anyone with informed consent, not just terminal patients, and includes oversight by a board with doctors, scientists, and ethicists. Critics warn of risks from unproven treatments, while supporters emphasize rigorous oversight.